Research
Revertant Autograft Replacement in Recessive Dystrophic Epidermolysis Bullosa
NEJM · By TokyoTomoyo TanakaMasukazu InoieJapan Tissue Engineering & Tokyo ·
The Brief
- A letter in the New England Journal of Medicine, titled "Revertant Autograft Replacement in Recessive Dystrophic Epidermolysis Bullosa", was published online on 2026-11-18.
- The letter appears in Volume 395, Issue 20, pages 2070–2073, of the New England Journal of Medicine, dated November 19, 2026.
- The title indicates it concerns autograft replacement using revertant tissue in recessive dystrophic epidermolysis bullosa, a rare inherited skin-blistering disease.
Why it matters
It reports on a treatment approach for recessive dystrophic epidermolysis bullosa, a severe inherited skin disease, which may matter to readers following genetic skin disorders and regenerative medicine.
Who’s affected
- clinicians and researchers in dermatology and inherited skin disease
- #epidermolysis bullosa
- #dermatology
- #autograft
- #rare disease
- #genetic disease
New England Journal of Medicine, Volume 395, Issue 20 , Page 2070-2073, November 19, 2026.